Latest News

ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
Written by: ESC Congress, Radcliffe Cardiology
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
ESC Congress 2024 Unveils its Hot Line Trials
Written by: Radcliffe Cardiology, ESC Congress
ESC Congress 2024 Unveils its Hot Line Trials
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood Pressure Control
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood…
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Written by: Radcliffe Cardiology, Greg Guillory, Karen Bell
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Written by: Radcliffe Cardiology, Karen Bell; Special Editor: Greg Guillory
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Written by: European Renal Association
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Featured Clinical Research to be Presented at SCAI 2024
Written by: SCAI 2024, Radcliffe Cardiology
Featured Clinical Research to be Presented at SCAI 2024
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
Written by: HRS Conference, Radcliffe Cardiology
Heart Rhythm 2024 Unveils its Late Breaking Trial Program
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations
Written by: EuroPCR 2024, Radcliffe Cardiology
EuroPCR Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations

External news

Written by: Cardiovascular Business
Cardiologist demand is on the rise—can hospitals keep up?
Written by: Cardiovascular Business
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
Written by: Cardiovascular Business
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Written by: Cardiovascular Business
SCCT Leaders Unpack the 2025 Medicare Payment Increase for Coronary CTA
Written by: Medscape
Could Weight Loss Injections Replace Obesity Surgery?
Written by: Medscape
Risk Score Predicts GI Bleeding Among Post-PCI Patients
Written by: Medscape
Goodbye CHADSVASc: Sex Complicates Stroke Risk Scoring in AF
Written by: Cardiovascular Business
Self-expanding vs. balloon-expandable TAVR valves: How they compare after 5 years
Written by: Cardiovascular Business
Cardiologist receives 35 months in prison for health insurance fraud
Written by: Cardiovascular Business
No-contact blood pressure and diabetes screening with AI shows promise